This year, I wrote three Global Fund funding requests for African HIV and TB programs. In Window 1 (20 March 2017), I wrote for Zimbabwe; in Window 2 (23 May 2017), I wrote for Zambia; and in Window 3 (28 August 2017), I wrote for Swaziland.
Both Zimbabwe’s and Zambia’s funding requests were invited to proceed directly to grant-making. Swaziland anticipates learning the outcome of its request in mid-October.
On 28 August 2017 (Window 3), Swaziland submitted a TB/HIV funding request to the Global Fund. The total request was for $93.8 million. When broken down, $47.2 million of this amount was within the country’s allocation, $1.5 million was a matching funds request for catalytic funding to prevent HIV among adolescent girls and young women (AGYW), and $45.1 million was a prioritized above allocation request (PAAR).
The Global Fund has unveiled its plans for the $260 million earmarked for multi-country approaches in the 2017-2019 allocations. The multi-country funding is part of a larger pot of money ($800 million) set aside for catalytic investments.
Kenya’s TB/HIV funding request to the Global Fund zeros in on HIV prevention among key populations and on finding missing TB cases
Kenya was among the 35 countries that submitted funding requests to the Global Fund in Window 2 on 23 May 2017. Kenya’s TB/HIV funding request was for $421.9 million, made up of a $256.4 million allocation request, $138.9 million prioritized above-allocation request (PAAR) and a $26.6 million matching funds request. A $112.0 million malaria funding request was submitted on the same day ($60.1 million within allocation and $51.9 million PAAR).
On 23 May 2017, Zambia submitted both TB/HIV and malaria funding requests, together worth just over $400 million. The TB/HIV funding request was for $306.8 million, of which $194.4 million constituted a within-allocation request, with a further $112.4 million as a prioritized above-allocation request (PAAR).
In our article, “More information on catalytic investments,” published on 17 April 2017 in GFO 309, we erroneously said that in order to access Matching Funds, a component of catalytic investments, countries must commit domestic funds equal to the matching amount requested. We wrote: “In addition, they must “match the Matching Funds” – i.e.
Review of Global Fund Window 1 funding requests reveals resurgence of malaria in Central and Eastern Africa, TRP says
The Technical Review Panel (TRP) says that based on its review of the funding requests in Window 1 of the current funding cycle, it believes there has been a resurgence of malaria in Central and Eastern Africa and that a change in approach is required.
The Global Fund Board has approved an extension of an existing malaria grant to Nigeria as well as a new one-year grant with a new principal recipient (PR) – all at no extra cost. The extension and the new grant will be financed by reinvesting savings identified in Nigeria’s current malaria grants. This will allow Nigeria to maintain essential malaria services to the end of 2017.